Epidemiology of invasive meningococcal disease in France in 2003

A Perrocheau1, M K Taha, D Levy-Bruhl

  • 1Unité des Maladies à Prévention Vaccinale, Département des Maladies Infectieuses, Institut de Veille Sanitaire, Saint Maurice, France.

Insights

National surveillance of invasive meningococcal disease (IMD) improved with enhanced reporting and analysis. Despite a 4% increase, IMD incidence decreased with age, with serogroup B being most common.

Area of Science:

  • Epidemiology
  • Infectious Disease Surveillance
  • Public Health

Background:

  • National surveillance of invasive meningococcal disease (IMD) relies on mandatory reporting.
  • Changes to the case definition in mid-2002 expanded surveillance to include non-microbiologically confirmed cases.
  • Enhancements to the IMD alert detection system in 2003 included daily reporting and weekly analysis.

Purpose of the Study:

  • To evaluate the exhaustivity of IMD surveillance through capture-recapture analysis.
  • To estimate the true incidence of IMD after correcting for underreporting.
  • To analyze trends, age-specific incidence, serogroup distribution, and case fatality rates of IMD.

Main Methods:

  • Capture-recapture analysis was employed to estimate underreporting.
  • Surveillance data from 2003 were analyzed for case numbers, incidence, and demographics.
  • Serogroup distribution and case fatality rates, including the impact of purpura fulminans and treatment, were assessed.

Main Results:

  • In 2003, 803 IMD cases were reported, with an estimated incidence of 1.78/100,000 after correction for underreporting.
  • A 4% increase in IMD was observed between 2002-2003 after excluding 'new' definition cases.
  • Incidence was highest in infants (<1 year) and young children (1-2 years), decreasing with age. Serogroups B (59%) and C (32%) were predominant. Case fatality rate was 12%.

Conclusions:

  • Enhanced surveillance and capture-recapture analysis provide a more accurate picture of IMD burden.
  • Targeted interventions, including mass prophylaxis and vaccination, were implemented in response to specific outbreaks and alert thresholds.
  • Early antibiotic treatment for purpura fulminans was associated with lower fatality rates.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.